TBC1D22A is a protein encoded by the TBC1D22A gene in humans. Its name reflects its classification: TBC1 indicates that it contains a TBC (Tre-2, Bub2, and Cdc16) domain, which is typically associated with proteins that have GTPase-activating protein (GAP) activity towards small GTPases of the Rab family. The 'D22A' suffix denotes its specific gene identifier within this family.Proteins in this group, including TBC1D22A, are regulators of intracellular vesicle trafficking. They function by inactivating Rab GTPases, which play critical roles in directing vesicle transport along cytoskeletal tracks to different cellular compartments such as the Golgi apparatus, endosomes, lysosomes, and the plasma membrane. By acting as GAPs, TBC domain-containing proteins like TBC1D22A help control the timing of vesicle fusion and release, ensuring that cargo is delivered to the correct location within the cell.
The TBC1D22A protein may have specific substrates among the Rab GTPases, although the precise Rab targets and the pathways that TBC1D22A regulates are not well-characterized compared to other members of the TBC domain-containing protein family. It is likely involved in processes such as membrane trafficking, signal transduction, and cellular growth and differentiation.Mutations or dysregulation of proteins that control vesicle trafficking, like TBC1D22A, can lead to a wide array of cellular dysfunctions and are often implicated in diseases including neurological disorders, cancer, and metabolic syndromes.
VEJA TAMBÉM
Items 1 to 10 of 11 total
Mostrar:
| Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
|---|---|---|---|---|---|---|
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
A brefeldina A perturba a função do aparelho de Golgi e pode afetar indiretamente a atividade da Rab GTPase relacionada com a TBC1D22A. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $58.00 $83.00 $140.00 $242.00 | 38 | |
O nocodazol perturba a dinâmica dos microtúbulos, afectando o transporte vesicular e, potencialmente, a função da TBC1D22A. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
A forskolina, ao elevar os níveis de AMPc, pode modular várias vias de sinalização, influenciando possivelmente a TBC1D22A. | ||||||
9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-β-D-ribofuranosyl]-9H-purin-6-amine | 1380288-87-8 | sc-500607 | 50 mg | $13500.00 | ||
O ML141 é um inibidor da Cdc42, com potencial impacto nas vias que se cruzam com a atividade da Rab GTPase relacionada com o TBC1D22A. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $148.00 $597.00 | 75 | |
O NSC23766 inibe a Rac1, o que pode ter efeitos a jusante nos processos celulares que envolvem a TBC1D22A. | ||||||
Cytochalasin D | 22144-77-0 | sc-201442 sc-201442A | 1 mg 5 mg | $145.00 $442.00 | 64 | |
A citocalasina D rompe os filamentos de actina, afectando a morfologia e o transporte celular, com potencial impacto na TBC1D22A. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
A Wortmannin é um inibidor da PI3K, influenciando o tráfico de vesículas e possivelmente a função da TBC1D22A. | ||||||
YM201636 | 371942-69-7 | sc-204193 | 5 mg | $213.00 | 6 | |
O YM201636 inibe a PIKfyve, afectando o tráfico endossomal, potencialmente relevante para as actividades da TBC1D22A. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
O Dynasore inibe a dinamina, afectando a endocitose e o tráfico vesicular, potencialmente relevante para o TBC1D22A. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $68.00 | 2 | |
A cloroquina, que afecta a função endossomal e lisossomal, pode ter implicações nos processos relacionados com o TBC1D22A. | ||||||